| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| 3' Untranslated Regions | 12 | 2019 | 183 | 1.900 |
Why?
|
| RNA, Messenger | 17 | 2020 | 2915 | 1.510 |
Why?
|
| CELF1 Protein | 2 | 2024 | 50 | 1.410 |
Why?
|
| MicroRNAs | 15 | 2019 | 949 | 1.290 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2024 | 249 | 1.270 |
Why?
|
| Gene Expression Profiling | 7 | 2016 | 1922 | 1.050 |
Why?
|
| Polyadenylation | 6 | 2016 | 56 | 0.960 |
Why?
|
| Protein Biosynthesis | 6 | 2022 | 678 | 0.950 |
Why?
|
| Gene Expression Regulation | 9 | 2016 | 2669 | 0.860 |
Why?
|
| Calcineurin | 12 | 2007 | 100 | 0.580 |
Why?
|
| Cytoplasmic Granules | 1 | 2018 | 52 | 0.570 |
Why?
|
| Stress, Physiological | 1 | 2018 | 272 | 0.510 |
Why?
|
| Immunity, Innate | 1 | 2019 | 415 | 0.490 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2016 | 82 | 0.480 |
Why?
|
| Breast Neoplasms | 3 | 2024 | 2771 | 0.460 |
Why?
|
| Statistics as Topic | 1 | 2015 | 261 | 0.440 |
Why?
|
| Mice | 30 | 2024 | 19045 | 0.430 |
Why?
|
| Oxidative Stress | 2 | 2018 | 874 | 0.430 |
Why?
|
| Flow Cytometry | 1 | 2016 | 824 | 0.410 |
Why?
|
| Animals | 37 | 2024 | 36521 | 0.410 |
Why?
|
| DNA Transposable Elements | 1 | 2014 | 189 | 0.410 |
Why?
|
| Apoptosis | 3 | 2020 | 1945 | 0.400 |
Why?
|
| Cell Line, Tumor | 9 | 2024 | 3800 | 0.390 |
Why?
|
| Alternative Splicing | 1 | 2015 | 379 | 0.390 |
Why?
|
| Genetic Vectors | 2 | 2014 | 967 | 0.380 |
Why?
|
| Ribosomes | 3 | 2022 | 141 | 0.350 |
Why?
|
| Transfection | 5 | 2019 | 1098 | 0.320 |
Why?
|
| T-Lymphocytes | 4 | 2016 | 1772 | 0.310 |
Why?
|
| Molecular Biology | 1 | 2008 | 80 | 0.290 |
Why?
|
| RNA, Untranslated | 1 | 2008 | 120 | 0.280 |
Why?
|
| DNA-Binding Proteins | 9 | 2020 | 2178 | 0.280 |
Why?
|
| Cell Line | 5 | 2020 | 2863 | 0.280 |
Why?
|
| Awards and Prizes | 1 | 2008 | 72 | 0.270 |
Why?
|
| Lymphopoiesis | 1 | 2007 | 10 | 0.270 |
Why?
|
| NFATC Transcription Factors | 9 | 2007 | 48 | 0.270 |
Why?
|
| Epithelial Cells | 2 | 2024 | 937 | 0.260 |
Why?
|
| RNA-Binding Proteins | 3 | 2016 | 623 | 0.250 |
Why?
|
| RNA Interference | 4 | 2016 | 548 | 0.250 |
Why?
|
| Genes, Reporter | 4 | 2016 | 399 | 0.240 |
Why?
|
| HeLa Cells | 5 | 2019 | 838 | 0.230 |
Why?
|
| Gene Expression | 1 | 2010 | 1622 | 0.230 |
Why?
|
| Herpesviridae | 1 | 2005 | 35 | 0.230 |
Why?
|
| Protein Stability | 1 | 2024 | 174 | 0.220 |
Why?
|
| Genome, Viral | 1 | 2005 | 184 | 0.220 |
Why?
|
| Humans | 35 | 2024 | 134196 | 0.220 |
Why?
|
| Cell Differentiation | 8 | 2016 | 2044 | 0.220 |
Why?
|
| Protein Kinase C | 1 | 2024 | 149 | 0.210 |
Why?
|
| Ubiquitination | 1 | 2024 | 186 | 0.210 |
Why?
|
| Sequence Analysis, RNA | 2 | 2014 | 424 | 0.210 |
Why?
|
| Sequence Alignment | 1 | 2005 | 633 | 0.210 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2015 | 508 | 0.200 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 3 | 2018 | 173 | 0.200 |
Why?
|
| Cell Movement | 2 | 2016 | 920 | 0.200 |
Why?
|
| Gene Dosage | 3 | 2020 | 458 | 0.200 |
Why?
|
| Phosphorylation | 2 | 2024 | 1713 | 0.190 |
Why?
|
| Chromosome Mapping | 1 | 2005 | 1125 | 0.190 |
Why?
|
| Host Cell Factor C1 | 1 | 2022 | 11 | 0.190 |
Why?
|
| Mice, Knockout | 8 | 2022 | 4012 | 0.190 |
Why?
|
| Homocystinuria | 1 | 2022 | 27 | 0.180 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2022 | 45 | 0.180 |
Why?
|
| Nuclear Proteins | 7 | 2015 | 1351 | 0.180 |
Why?
|
| Oxidoreductases | 1 | 2022 | 103 | 0.180 |
Why?
|
| Cell Proliferation | 6 | 2016 | 2562 | 0.180 |
Why?
|
| Lymphocyte Activation | 3 | 2016 | 695 | 0.180 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2022 | 115 | 0.170 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2020 | 17 | 0.170 |
Why?
|
| RNA | 2 | 2018 | 607 | 0.160 |
Why?
|
| Cell Survival | 3 | 2016 | 890 | 0.160 |
Why?
|
| Transcription Factors | 8 | 2006 | 2735 | 0.160 |
Why?
|
| Proteostasis | 1 | 2020 | 38 | 0.160 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2020 | 78 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 6 | 2019 | 4882 | 0.160 |
Why?
|
| Autophagy | 3 | 2018 | 429 | 0.160 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 1999 | 24 | 0.160 |
Why?
|
| Sirtuins | 1 | 2019 | 21 | 0.150 |
Why?
|
| Calcium | 5 | 2016 | 1148 | 0.150 |
Why?
|
| RNA Isoforms | 2 | 2016 | 6 | 0.150 |
Why?
|
| Telomere Shortening | 1 | 2019 | 36 | 0.150 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 139 | 0.150 |
Why?
|
| Jurkat Cells | 2 | 2016 | 94 | 0.150 |
Why?
|
| Eukaryotic Initiation Factor-4A | 1 | 2018 | 10 | 0.150 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2018 | 56 | 0.150 |
Why?
|
| Signal Transduction | 12 | 2018 | 4936 | 0.150 |
Why?
|
| src-Family Kinases | 1 | 2018 | 97 | 0.140 |
Why?
|
| 5' Untranslated Regions | 1 | 2018 | 61 | 0.140 |
Why?
|
| Cloning, Molecular | 3 | 2010 | 912 | 0.140 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 71 | 0.140 |
Why?
|
| Repressor Proteins | 2 | 2022 | 874 | 0.140 |
Why?
|
| RNA, Plant | 1 | 2017 | 9 | 0.140 |
Why?
|
| Cells, Cultured | 11 | 2019 | 3180 | 0.140 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2018 | 225 | 0.130 |
Why?
|
| Membrane Glycoproteins | 2 | 2017 | 432 | 0.130 |
Why?
|
| Trehalose | 1 | 2017 | 21 | 0.130 |
Why?
|
| RNA, Long Noncoding | 1 | 2020 | 248 | 0.130 |
Why?
|
| Homozygote | 1 | 2019 | 571 | 0.130 |
Why?
|
| Myoblasts, Skeletal | 1 | 2016 | 12 | 0.130 |
Why?
|
| Wnt Signaling Pathway | 1 | 2018 | 208 | 0.130 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2016 | 23 | 0.130 |
Why?
|
| Heterozygote | 1 | 2019 | 732 | 0.130 |
Why?
|
| Kinetics | 1 | 2018 | 1353 | 0.130 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 2016 | 12 | 0.130 |
Why?
|
| Protein Array Analysis | 1 | 2016 | 107 | 0.130 |
Why?
|
| Lung Neoplasms | 2 | 2020 | 1783 | 0.130 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2016 | 26 | 0.130 |
Why?
|
| CD5 Antigens | 1 | 2016 | 35 | 0.120 |
Why?
|
| RNA Stability | 2 | 2014 | 87 | 0.120 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 1144 | 0.120 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 105 | 0.120 |
Why?
|
| Neoplasms, Experimental | 1 | 2016 | 223 | 0.120 |
Why?
|
| Cleavage And Polyadenylation Specificity Factor | 1 | 2015 | 15 | 0.120 |
Why?
|
| Glycolysis | 1 | 2016 | 173 | 0.120 |
Why?
|
| NADPH Oxidases | 1 | 2016 | 115 | 0.120 |
Why?
|
| Genes, myc | 1 | 2015 | 107 | 0.120 |
Why?
|
| HIV-1 | 1 | 1999 | 489 | 0.120 |
Why?
|
| Spliceosomes | 1 | 2015 | 57 | 0.120 |
Why?
|
| Neuroprotective Agents | 1 | 2017 | 169 | 0.120 |
Why?
|
| Alleles | 2 | 2019 | 1724 | 0.120 |
Why?
|
| Myocardium | 2 | 2014 | 1041 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2018 | 2137 | 0.120 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 189 | 0.120 |
Why?
|
| Transcription, Genetic | 4 | 2015 | 1762 | 0.110 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 219 | 0.110 |
Why?
|
| Female | 9 | 2024 | 72037 | 0.110 |
Why?
|
| Hypoxia | 1 | 2016 | 268 | 0.110 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2007 | 452 | 0.110 |
Why?
|
| Statistics, Nonparametric | 1 | 2015 | 454 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 512 | 0.110 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 400 | 0.110 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 2014 | 199 | 0.110 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 285 | 0.110 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 606 | 0.110 |
Why?
|
| Lymphocytes | 3 | 2015 | 433 | 0.100 |
Why?
|
| Calcium Signaling | 3 | 2014 | 255 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 456 | 0.100 |
Why?
|
| ROC Curve | 1 | 2015 | 611 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 546 | 0.100 |
Why?
|
| Hyaluronan Receptors | 1 | 2012 | 69 | 0.100 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2015 | 312 | 0.100 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2014 | 243 | 0.100 |
Why?
|
| Databases, Genetic | 1 | 2015 | 507 | 0.100 |
Why?
|
| Mutation | 5 | 2022 | 6350 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2015 | 709 | 0.090 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 179 | 0.090 |
Why?
|
| Liver Cirrhosis | 1 | 2019 | 948 | 0.090 |
Why?
|
| Phenotype | 3 | 2019 | 4610 | 0.090 |
Why?
|
| Embryo, Mammalian | 3 | 2022 | 467 | 0.090 |
Why?
|
| Neoplasms | 2 | 2018 | 3035 | 0.090 |
Why?
|
| Mice, Transgenic | 7 | 2017 | 2538 | 0.080 |
Why?
|
| Uridine Monophosphate | 1 | 2009 | 9 | 0.080 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2010 | 126 | 0.080 |
Why?
|
| Models, Biological | 5 | 2020 | 1538 | 0.080 |
Why?
|
| Immune System | 1 | 2010 | 98 | 0.080 |
Why?
|
| Neurons | 3 | 2017 | 2051 | 0.080 |
Why?
|
| Disease Models, Animal | 6 | 2022 | 4802 | 0.070 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2006 | 109 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 377 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 3 | 2017 | 399 | 0.070 |
Why?
|
| Parkinson Disease | 1 | 2016 | 740 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2022 | 1051 | 0.070 |
Why?
|
| Massachusetts | 1 | 2008 | 131 | 0.070 |
Why?
|
| Plants | 1 | 2008 | 52 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 3057 | 0.070 |
Why?
|
| Genetic Variation | 1 | 2015 | 1630 | 0.070 |
Why?
|
| Mental Disorders | 1 | 2015 | 890 | 0.070 |
Why?
|
| Thymus Gland | 1 | 2007 | 106 | 0.070 |
Why?
|
| Down-Regulation | 3 | 2019 | 718 | 0.070 |
Why?
|
| Interleukin-6 | 1 | 2009 | 450 | 0.070 |
Why?
|
| Atrial Fibrillation | 1 | 2014 | 702 | 0.070 |
Why?
|
| Mesoderm | 2 | 2004 | 113 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2008 | 396 | 0.070 |
Why?
|
| Genomics | 1 | 2015 | 1678 | 0.070 |
Why?
|
| Base Sequence | 3 | 2016 | 3180 | 0.060 |
Why?
|
| HIV Infections | 1 | 1999 | 2073 | 0.060 |
Why?
|
| Ribonuclease III | 1 | 2007 | 103 | 0.060 |
Why?
|
| Antigens, T-Independent | 1 | 2006 | 1 | 0.060 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 720 | 0.060 |
Why?
|
| Chromosomes, Mammalian | 1 | 2006 | 45 | 0.060 |
Why?
|
| Synapses | 1 | 2010 | 470 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2008 | 1070 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2007 | 324 | 0.060 |
Why?
|
| Protein Subunits | 2 | 2022 | 174 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2016 | 6612 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2019 | 825 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2012 | 1070 | 0.060 |
Why?
|
| Insulin-Secreting Cells | 1 | 2006 | 150 | 0.060 |
Why?
|
| Keratinocytes | 1 | 2005 | 66 | 0.060 |
Why?
|
| Myoblasts, Cardiac | 1 | 2004 | 6 | 0.060 |
Why?
|
| Endocardium | 1 | 2004 | 56 | 0.060 |
Why?
|
| Heart Valves | 1 | 2004 | 54 | 0.060 |
Why?
|
| Enzyme Activation | 2 | 2020 | 651 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2004 | 172 | 0.050 |
Why?
|
| Growth Cones | 1 | 2003 | 16 | 0.050 |
Why?
|
| Protein Transport | 2 | 2020 | 390 | 0.050 |
Why?
|
| Urinary Tract | 1 | 2004 | 68 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 596 | 0.050 |
Why?
|
| Muscle Proteins | 1 | 2006 | 427 | 0.050 |
Why?
|
| Down Syndrome | 1 | 2006 | 232 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2006 | 542 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 497 | 0.050 |
Why?
|
| Ureter | 1 | 2004 | 100 | 0.050 |
Why?
|
| Nervous System | 1 | 2003 | 131 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2019 | 260 | 0.050 |
Why?
|
| Cytoplasm | 2 | 2020 | 304 | 0.050 |
Why?
|
| Organelle Biogenesis | 1 | 2022 | 19 | 0.050 |
Why?
|
| Molecular Sequence Data | 3 | 2009 | 3978 | 0.050 |
Why?
|
| Phylogeny | 2 | 2007 | 781 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2004 | 445 | 0.050 |
Why?
|
| Male | 5 | 2022 | 66197 | 0.050 |
Why?
|
| Vitamin B 12 | 1 | 2022 | 63 | 0.050 |
Why?
|
| Ribosomal Proteins | 1 | 2022 | 76 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 1626 | 0.050 |
Why?
|
| Evolution, Molecular | 1 | 2005 | 710 | 0.040 |
Why?
|
| Cell Nucleus | 3 | 2017 | 691 | 0.040 |
Why?
|
| RNA Splicing | 2 | 2015 | 254 | 0.040 |
Why?
|
| Monitoring, Immunologic | 1 | 2020 | 15 | 0.040 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2020 | 8 | 0.040 |
Why?
|
| eIF-2 Kinase | 1 | 2020 | 36 | 0.040 |
Why?
|
| Cell Count | 1 | 2020 | 241 | 0.040 |
Why?
|
| Hippocampus | 2 | 2010 | 864 | 0.040 |
Why?
|
| Calcium Channels, L-Type | 1 | 1999 | 54 | 0.040 |
Why?
|
| Nicotinamide Mononucleotide | 1 | 2019 | 5 | 0.040 |
Why?
|
| Kenya | 1 | 1999 | 63 | 0.040 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2020 | 131 | 0.040 |
Why?
|
| Mitosis | 1 | 2020 | 205 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 117 | 0.040 |
Why?
|
| Mitochondria, Liver | 1 | 2019 | 36 | 0.040 |
Why?
|
| Genes, Viral | 1 | 1999 | 186 | 0.040 |
Why?
|
| Telomere Homeostasis | 1 | 2019 | 47 | 0.040 |
Why?
|
| Sirtuin 1 | 1 | 2019 | 55 | 0.040 |
Why?
|
| Lung | 1 | 2006 | 1578 | 0.040 |
Why?
|
| Proto-Oncogenes | 1 | 2018 | 37 | 0.040 |
Why?
|
| Triterpenes | 1 | 2018 | 25 | 0.040 |
Why?
|
| Telomerase | 1 | 2019 | 179 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2020 | 541 | 0.030 |
Why?
|
| RNA Helicases | 1 | 2018 | 73 | 0.030 |
Why?
|
| Gene Deletion | 2 | 2015 | 811 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2018 | 233 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 357 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1999 | 358 | 0.030 |
Why?
|
| DNA, Viral | 1 | 1999 | 500 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 1999 | 453 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2004 | 1043 | 0.030 |
Why?
|
| Food Handling | 1 | 2017 | 18 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 2009 | 2793 | 0.030 |
Why?
|
| Brassica | 1 | 2017 | 17 | 0.030 |
Why?
|
| Biological Availability | 1 | 2017 | 151 | 0.030 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2017 | 42 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 110 | 0.030 |
Why?
|
| Cell Fusion | 1 | 2016 | 39 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2016 | 51 | 0.030 |
Why?
|
| DNA Damage | 1 | 2020 | 547 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2016 | 97 | 0.030 |
Why?
|
| Rotenone | 1 | 2016 | 13 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2016 | 103 | 0.030 |
Why?
|
| Poly A | 1 | 2016 | 60 | 0.030 |
Why?
|
| NADPH Oxidase 2 | 1 | 2016 | 41 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2018 | 624 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2017 | 174 | 0.030 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2016 | 111 | 0.030 |
Why?
|
| Splicing Factor U2AF | 1 | 2015 | 12 | 0.030 |
Why?
|
| Ribonucleoprotein, U2 Small Nuclear | 1 | 2015 | 11 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 399 | 0.030 |
Why?
|
| Ribonucleoproteins | 1 | 2015 | 66 | 0.030 |
Why?
|
| RNA Splicing Factors | 1 | 2015 | 55 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2015 | 69 | 0.030 |
Why?
|
| Cleavage Stimulation Factor | 1 | 2014 | 3 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2016 | 211 | 0.030 |
Why?
|
| Myotonic Dystrophy | 1 | 2016 | 151 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2016 | 487 | 0.030 |
Why?
|
| Introns | 1 | 2015 | 319 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 2 | 2010 | 403 | 0.030 |
Why?
|
| Calcineurin Inhibitors | 2 | 2005 | 29 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2016 | 483 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2015 | 218 | 0.030 |
Why?
|
| Astrocytes | 1 | 2017 | 273 | 0.030 |
Why?
|
| Transgenes | 2 | 2006 | 346 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2015 | 780 | 0.030 |
Why?
|
| Gene Duplication | 1 | 2015 | 372 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2007 | 1138 | 0.030 |
Why?
|
| Cell Division | 2 | 2005 | 773 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 1332 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2015 | 458 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 1999 | 1835 | 0.020 |
Why?
|
| Disease Progression | 1 | 1999 | 2265 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 745 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2017 | 918 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 1013 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 645 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2014 | 914 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2012 | 212 | 0.020 |
Why?
|
| Action Potentials | 1 | 2014 | 523 | 0.020 |
Why?
|
| Liver | 1 | 2019 | 1876 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 2016 | 551 | 0.020 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2010 | 37 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 407 | 0.020 |
Why?
|
| UDPglucose-Hexose-1-Phosphate Uridylyltransferase | 1 | 2009 | 3 | 0.020 |
Why?
|
| Dendritic Spines | 1 | 2010 | 61 | 0.020 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2010 | 72 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 206 | 0.020 |
Why?
|
| Biomarkers | 1 | 1999 | 3433 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2010 | 397 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2004 | 396 | 0.020 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2010 | 152 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2009 | 247 | 0.020 |
Why?
|
| Calcium Channels | 2 | 1999 | 166 | 0.020 |
Why?
|
| raf Kinases | 1 | 2007 | 7 | 0.020 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2007 | 13 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2007 | 60 | 0.020 |
Why?
|
| Luciferases, Firefly | 1 | 2007 | 13 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 1044 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2007 | 93 | 0.020 |
Why?
|
| Antigens | 1 | 2007 | 153 | 0.020 |
Why?
|
| RNA Polymerase III | 1 | 2007 | 43 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2007 | 272 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 3678 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 150 | 0.020 |
Why?
|
| Pulmonary Surfactant-Associated Proteins | 1 | 2006 | 5 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2007 | 88 | 0.020 |
Why?
|
| Thyroid Nuclear Factor 1 | 1 | 2006 | 16 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2007 | 169 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2006 | 28 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2006 | 50 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 672 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2006 | 169 | 0.020 |
Why?
|
| Hyperinsulinism | 1 | 2006 | 71 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2010 | 1041 | 0.020 |
Why?
|
| Plasmids | 1 | 2007 | 531 | 0.020 |
Why?
|
| Ligands | 1 | 2007 | 573 | 0.020 |
Why?
|
| Immunologic Memory | 1 | 2007 | 200 | 0.020 |
Why?
|
| Salivary Glands | 1 | 2006 | 35 | 0.020 |
Why?
|
| Germinal Center | 1 | 2006 | 38 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2006 | 44 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2006 | 98 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2006 | 198 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2005 | 92 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 2006 | 219 | 0.010 |
Why?
|
| Alopecia | 1 | 2005 | 41 | 0.010 |
Why?
|
| Receptor, Notch1 | 1 | 2005 | 80 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2006 | 235 | 0.010 |
Why?
|
| Brain | 1 | 2017 | 3226 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2006 | 337 | 0.010 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2004 | 8 | 0.010 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 2004 | 8 | 0.010 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2004 | 46 | 0.010 |
Why?
|
| PAX3 Transcription Factor | 1 | 2004 | 29 | 0.010 |
Why?
|
| Time Factors | 1 | 2014 | 6595 | 0.010 |
Why?
|
| Paired Box Transcription Factors | 1 | 2004 | 77 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2004 | 170 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2006 | 335 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 897 | 0.010 |
Why?
|
| Luciferases | 1 | 2004 | 139 | 0.010 |
Why?
|
| Hypertrophy | 1 | 2004 | 104 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 2006 | 240 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 2004 | 151 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2007 | 625 | 0.010 |
Why?
|
| Growth Hormone | 1 | 2004 | 151 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2004 | 400 | 0.010 |
Why?
|
| Netrin-1 | 1 | 2003 | 6 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2003 | 28 | 0.010 |
Why?
|
| Type C Phospholipases | 1 | 2003 | 29 | 0.010 |
Why?
|
| Morphogenesis | 1 | 2004 | 215 | 0.010 |
Why?
|
| Models, Immunological | 1 | 2003 | 38 | 0.010 |
Why?
|
| Heat-Shock Proteins | 1 | 2004 | 204 | 0.010 |
Why?
|
| Receptors, Antigen | 1 | 2003 | 34 | 0.010 |
Why?
|
| Nerve Growth Factors | 1 | 2003 | 76 | 0.010 |
Why?
|
| Rats | 1 | 2010 | 3876 | 0.010 |
Why?
|
| Growth Substances | 1 | 2003 | 114 | 0.010 |
Why?
|
| Age Factors | 1 | 2010 | 2997 | 0.010 |
Why?
|
| Integrases | 1 | 2004 | 163 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2006 | 790 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2003 | 132 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2006 | 810 | 0.010 |
Why?
|
| Cell Communication | 1 | 2003 | 192 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2004 | 360 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2004 | 352 | 0.010 |
Why?
|
| Zebrafish | 1 | 2004 | 421 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 1434 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2005 | 709 | 0.010 |
Why?
|
| Oxygen | 1 | 2004 | 580 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2003 | 510 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2007 | 1621 | 0.010 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 1999 | 34 | 0.010 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 1999 | 66 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 1999 | 167 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1999 | 89 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1999 | 281 | 0.010 |
Why?
|
| Aging | 1 | 2006 | 1308 | 0.010 |
Why?
|
| Biological Transport | 1 | 1999 | 371 | 0.010 |
Why?
|
| Kidney | 1 | 2006 | 1404 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1999 | 673 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2006 | 1419 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1999 | 503 | 0.010 |
Why?
|